Junyan Wu

Curcumin and its nano-formulations: Defining triple-negative breast cancer targets through network pharmacology, molecular docking, and experimental verification

Zhicheng Deng, Guanghui Chen, Yonghui Shi et al. · Frontiers in Pharmacology · 2022 · 54 citations · Full text

Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours

Jian Zhang, Rujiao Liu, Shuiping Gao et al. · npj Breast Cancer · 2023 · 46 citations · Full text

A polymeric nanocarrier that eradicates breast cancer stem cells and delivers chemotherapeutic drugs

Li Lv, Yonghui Shi, Zhicheng Deng et al. · Biomaterials Research · 2023 · 15 citations · Full text